MaaT Pharma Logo

MaaT Pharma

MAAT | PA

Overview

Corporate Details

ISIN(s):
FR0012634822 (+1 more)
LEI:
969500CQQB6XUNW6CN97
Country:
France
Address:
70 AVENUE TONY GARNIER, 69007 LYON
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

MaaT Pharma is a clinical-stage biotechnology company specializing in the development of microbiome-based therapeutics to improve survival outcomes for cancer patients. The company focuses on modulating the immune system through innovative gut microbiome-driven therapies. Its pipeline targets severe oncology diseases and complications like graft-versus-host disease (GvHD), a frequent side effect of stem cell transplantation. MaaT Pharma leverages an integrated approach that includes an AI-powered drug development platform and versatile cGMP manufacturing capabilities. A pioneer in its field, the company was the first to advance a microbiome-based therapy into a Phase 3 clinical trial for haemato-oncology.

Social Media

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for MaaT Pharma. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-07-28 07:30
Capital/Financing Update
Informations privilégiées / Autres communiqués
French 158.6 KB
2025-07-28 07:30
Capital/Financing Update
Inside Information / Other news releases
English 106.4 KB
2025-06-13 07:30
Legal Proceedings Report
Informations privilégiées / Autres communiqués
French 127.5 KB
2025-06-13 07:30
Earnings Release
Inside Information / Other news releases
English 151.0 KB
2025-06-02 18:30
Legal Proceedings Report
Inside Information / Other news releases
English 135.6 KB
2025-06-02 18:30
Regulatory News Service
Informations privilégiées / Autres communiqués
French 166.2 KB
2025-05-14 18:00
Legal Proceedings Report
Inside Information / Other news releases
English 121.4 KB
2025-05-14 18:00
Regulatory News Service
Informations privilégiées / Autres communiqués
French 117.5 KB
2025-05-14 07:30
Pre-Annual General Meeting Information
Inside Information / Other news releases
English 71.4 KB
2025-05-14 07:30
Pre-Annual General Meeting Information
Informations privilégiées / Autres communiqués
French 147.0 KB
2025-05-13 18:00
Earnings Release
Informations privilégiées / Autres communiqués
French 131.8 KB
2025-05-13 18:00
Earnings Release
Inside Information / Other news releases
English 118.8 KB
2025-05-12 07:30
Earnings Release
Informations privilégiées / Autres communiqués
French 140.1 KB
2025-05-12 07:30
Regulatory News Service
Inside Information / Other news releases
English 861.7 KB
2025-04-28 18:00
Regulatory News Service
Informations privilégiées / Autres communiqués
French 958.7 KB

Automate Your Workflow. Get a real-time feed of all MaaT Pharma filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for MaaT Pharma via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2024-07-12 N/A Other Sell 8 60.87 EUR
2024-07-11 N/A Other Sell 57 436.14 EUR
2023-12-22 N/A Other Buy 2,940 14,994.00 EUR
2023-12-22 N/A Other Buy 1,960 9,996.00 EUR
2023-09-27 N/A Other Buy 500 3,050.00 EUR

Peer Companies

Company Country Ticker View
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
AcuCort AB Logo
Develops a rapid oral film for acute allergies, croup, and chemo-induced nausea.
Sweden ACUC
Advicenne Logo
Develops and commercializes therapies for rare renal diseases for patients of all ages.
France ALDVI
AegirBio AB Logo
Makes saliva-based diagnostics accessible for at-home & pro health & drug monitoring.
Sweden AEGIR
Aelis Farma Logo
Developing novel CB1 receptor inhibitors for treating brain and CNS disorders.
France AELIS
AGRONOMICS LIMITED Logo Isle of Man ANIC
ALK-Abelló Logo
Develops allergy immunotherapy (AIT) and emergency treatments for severe allergies.
Denmark ALK